C4 Therapeutics (C4T) is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases, reduce drug resistance, achieve higher potency, and decrease side effects through greater selectivity.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Nov 3, 2022
Sep 29, 2022
Sep 26, 2022
December 1, 2022 at 9:15 AM EST
November 8, 2022 at 2:00 PM PST
October 3, 2022 at 9:50 AM EDT